Ocular drug delivery is challenging due to the eye’s unique anatomy and physiology, which limit drug absorption and distribution. Traditional methods like eye drops have poor bioavailability and often require frequent dosing. In-situ gel systems, liquid formulations that transform into a gel upon contact with physiological conditions (pH, temperature, or ions in tear fluid), offer several advantages for ocular drug delivery. Ganciclovir was incorporated into a thermoresponsive in situ gel base. Nine formulations were prepared using the cold technique and a 3² full factorial design. The physical properties of ganciclovir gel, including clarity, pH, viscosity, gelation temperature, and gelation time, were scrutinized. In vitro drug release was assessed using a dialysis membrane method, and ocular toxicity was evaluated in a rabbit model. Poloxamer 407 and HPMC E-50 LV were used to prepare the gel, with the 3² factorial design analyzing the effects of varying concentrations on the gel’s viscosity, gelation temperature, and gelation time. The optimized in-situ gel formulation (Batch B5) contained 15% w/v poloxamer 407 and 1% w/v HPMC E-50 LV, achieving a viscosity of 64.81 cPs, with a gelation temperature of 39.0 °C and a gelation time of 183 s. This formulation demonstrated better permeability and sustained ganciclovir release than a commercial formulation. Ocular toxicity studies confirmed that the formulation was non-irritating and well-tolerated. Overall, the gel showed suitable physical properties, sustained drug release over 12 h, and significant potential for enhancing drug bioavailability and treatment efficacy for ocular infections. These findings confirm that the optimized ganciclovir in situ gel preparation improves eye permeation and prolongs ocular retention time, thus enhancing its therapeutic efficacy. Its sustained release and prolonged retention time make it a promising alternative to conventional eye drops, offering better patient compliance and efficacy.
11 February 2025 in Zeitschrift für Naturforschung C
Sericin, a protein extracted from the cocoons of silkworms, has recently become an attractive biomaterial due to its potential as a good candidate for wound healing especially wounds seen in diabetic and immune-compromised patients. This review discusses the special biological nature of sericin such as its water-solubility and inherent moisturizing properties, antimicrobial, and antioxidant activities, which can act synergistically to foster ideal conditions for wound healing. The incorporation of sericin into composite wound dressings along with other natural and synthetic polymers was found to improve the mechanical properties, biocompatibility, and overall therapeutic performance. Moreover, the review draws attention toward sericin-based materials in diabetic wound healing with a focus on promoting rapid tissue regeneration and cell proliferation and enhancing clinical outcomes that conventional therapeutics cannot serve. The review also discusses the challenges associated with the production and application of sericin-based wound dressings and outlines the prospects for this emerging field. As research continues to advance, silk sericin holds the potential to revolutionize wound care, offering innovative solutions for the effective and holistic management of complex wounds.
Central nervous system disorders are likely to have a substantial effect on the worldwide healthcare demands of humanity in this era. Alzheimer's disease (AD) is a senile decay of neurons. Extracellular beta-amyloid accumulation and intracellular tau hyperphosphorylation are two key characteristics of the pathogenesis of AD. Because of the multifactorial character of many disorders, new medicine-based psychoactive treatments have had limited success. As a result, there is a growing demand for innovative products that can target different receptors and improve behavioral abilities on their own or in combination with established treatments. In recent years, both industrialized and developing countries have seen a surge in herbal products based on traditional knowledge. According to recent research, bacoside and its congeners can dramatically lower the build-up of amyloid-β plaques, which are a defining feature of AD. This decrease is explained by bacoside's capacity to regulate β-secretase activity, which lowers the production of amyloid-β. Ayurveda is a medical science that focuses on the use of naturally occurring plant products to treat ailments. Many neuroprotective plants are said to be found in Ayurveda. The key physiological dysfunctions linked to tau aggregates, which contribute to dementia and behavioral inconsistencies, include the formation of reactive oxygen species, augmented neuronal swelling, and neurotoxicity. Here, we have focused on bacopa as an anti-Alzheimer medication. Bacoside A, Baccoside B, Apigenin, Betullinic acid, etc. are the pharmacologically active congeners of Brahmi belonging to several chemical families. In this review, the neuroprotective properties, pharmacological effectiveness, and molecular mechanism of bacoside scaffolds against AD have been discussed.